Biobanks Market
By Component (Hardware, Software, Consumables, and Service),
By Sample Type (Blood Product, Tissue, Biological Fluids, Cell Lines, Nucleic Acids, and Others),
By Application (Therapeutic and Research),
By Region (North America, Europe, Asia-Pacific, Latin America, Middle East & Africa):
Global Analysis and Forecast 2023-2033
The global biobanks market showcased a revenue of USD 49.3 billion in 2022 and is projected to witness a compounded annual growth rate (CAGR) of more than 6% over the forecast period of 2023-2033.
Russia-Ukraine War Impact
Market Scope
About the Market
Impact of COVID-19
Global Economic Slowdown
Market Dynamics
Driver
Restrain
Opportunity
Recent Developments
Synopsis
How is this report helpful
FAQ's
Report Coverage
Related Reports
Biobanks are simply repositories of biological fluids and tissue samples that can be used for research. Biobanks can also refer to collections of medical data or health information. These are utilized to study biological aspects and make some conclusions about treatment approaches or disease states being studied. The growing interest in genomics, precision medicine, and regenerative therapies are primary factors boosting the market growth of Biobanks.
Genomic studies require a large pool of genetic samples to research genetic defects and possible treatment approaches. The rise in genetic disorders and cancer prevalence is triggering more genomic studies. On the parallel side, the rise in chronic disorders pushes the need for research and studies on biological samples to deduce the necessary information for chronic disorder management. Recent years have witnessed advancements in cancer biology and the role of genetics in the same. Genetic information is increasingly being used to understand cancer and other disease states. The advent of precision medicine which targets genetic variability as a basis for personalized treatment is also largely dependent on research and studies for its future development. Precision medicine looks forward to understanding the genetic differences of each individual and thus giving them suitable personalized end treatment. This personalized medicine approach has greatly used genetic pools of samples and data to understand genetic variability. Regenerative medicine or stem cell therapies, which aim at regenerating or repairing damaged tissue or organ, is also dependent on samples of biological cells that can be used to replace the damaged ones. Oncology, genetics, precision medicine, and regenerative therapies are newer therapeutic approaches that have boosted the need for Biobanks.
Another fundamental factor boosting Biobank's presence in the market is the need for blood transfusion and products for treatment approaches. Blood plasma is often transferred from recovered patients to sick patients in order to administer necessary antibodies that can be crucial to fight the disease state. Such transfusion procedures have also triggered the market growth for Biobanks.
Impact of Russia-Ukraine war on Biobanks Market
The biobnanks market has a notable impact due to the ongoing Russia-Ukraine war. The biobanks market is heavily dependent on the funds received by the government and global organisations towards research and development. Dissipation of funds towards managing bottom line by major companies and re-allocation of funds for war by the Russian and Ukrainian government has led to cash crunch within the biobanks market. Furthermore, lack of proper environment for research and development, followed by lack of samples, and existing samples being destroyed due to destruction of infrastructure in these countries has heavily impacted the market and will also pose a threat in line with future research and development opportunities. Fleeing of skilled individuals working within the vertical from the war prone countries has led to shortage of people capable to operate the market effectively. Other later impacts such as inflation, cross border trade restriction, shortage of vital materials required for smooth operations is also impacting the business opportunities within the region.
Biobanks: Market Scope
The Biobanks market is primarily divided into four segments component, sample type, and application. Furthermore, these segments are subdivided into respective categories and cross-referenced to North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa for regional analysis. The component segment is further categorized into Hardware, Software, Consumables, and Service. The sample type segment is segregated into Blood Products, Tissue, Biological Fluids, Cell Lines, Nucleic Acids, and Others. The application segment of the Biobanks market is bifurcated into Therapeutic and Research. Each of these segments is further classified into regions: North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. The historical dataset of 2018-2022 is provided in the three reports, whereas the forecast period of 2023-2033 is offered.
Service component to witness highest growth rate
The component segment is further subdivided into Hardware, software, consumables, and service. The service segment is projected to witness the highest market growth. Biobanking or repository services are utilized in Academic research, precision medicine, and regenerative therapies. The growing use of service segments has necessitated the need to preserve biosamples. Biosamples service comes in handy when patient data have to be compared to standard data. Not only this, the medical data is also utilized to derive key parameters that vary from one individual to another and hence can be significant to precision medicine studies. Advances in regenerative therapies also demand healthy cells that can be used to replace or repair damaged organs.
Blood products to capture the highest market share within the sample segment
Blood is the most significant connectivity tissue that carries numerous electrolytes, hormones, transmitters, and biochemical constituents in order to maintain tissue functioning. Such crucial constituents in the blood make it one of the most dynamic body fluids that can give various insights about a patient's biochemical functioning and, thus, their organ health. Academic researchers often look for changes in blood composition to deduce a diseased state and the impact of their experimental treatment approaches. Blood transfusion also drives market growth for this segment, where plasma constituents are administered to sick patients in order to gain their effective recovery. Blood samples are studied to represent a biochemical print of a particular disease state and thus also aid in clinical studies.
Research application to show the highest growth rate
Research and development is the backbone for understanding various disease states and their therapeutic approaches. Advanced therapies such as precision medicine, gene or cell therapy, and oncology largely depend on research insights to develop effective treatment models. Academic research also utilizes biosamples to compare disease states and mark changes from one individual to another. Variability patterns have been crucial to understanding how precision medicine works. The associated medical data with biological tissues has also been of significant use to research. Big data is making way for the integration of AI and Analytics. All these developments rely on research and associated biological samples.
Asia-Pacific to witness the highest growth rate in the forecast period
Asia-pacific presents high population dynamics within India and China. The rise in the geriatric population within this region presents the humongous potential for advanced therapies such as precision medicine or regenerative therapies and thus associated Biobanks. The Asia-Pacific region is witnessing increasing penetration of Biobanks and innovative treatment approaches. Initiatives to integrate data and AI also represent great potential within the Asia-Pacific region.
Impact of COVID-19 on Biobanks Industry
Covid-19 created a surge in the need for vaccines and other medical developments. It opened up horizons for drug discovery and development. The pandemic witnessed various types of research conducted on patients' biological samples to deduce the impact of the viruses and biological responses to the tissue of interest. Academic research was continuously peaking to discover new drug molecules' impact on the viral concentration of tissues. This propelled the market growth of Biobanks and also the research and development segment. COVID-19 was a very rigorous time for the entire Healthcare world and made a revolutionary impact on the entire research and Biobanks segment for coming years.
Biobanks: Market Dynamics
The market dynamics section of the report covers an in-depth analysis of drivers, restraints, and opportunities impacting the Biobanks market. The report also encompasses major market strategies practiced by the industry, followed by patent analysis, product analysis, competitive benchmarking of companies, PORTER and PESTLE analysis of the Biobanks industry, pricing analysis, and geographic competitiveness to provide a detailed understanding. The major players operating in the market are Brooks Life Sciences, BioLifeSolutions Inc, BioCision, Cell&Co BioServices, Hamilton Company, Thermo Fisher Scientific Inc, Tecan Trading AG, TTP Labtech, Taylor-Wharton, and VWR International, LLC. These companies cumulatively hold the majority of Biobank's market share and actively undergoes strategic development, such as new product launch, merger, collaboration, business expansion, acquisition, and long-term contracts to ensure market penetration. These companies also largely focus on research and development to gain technological competitiveness in the market. A detailed analysis of these companies is offered in the report.
Driver: Growing Research to combat chronic disorders.
The rise in chronic disorders is a major concern for the healthcare industry since it can greatly impact mortality and morbidity rates. Quality of life and human beings is deeply interconnected to genetics, lifestyle, and environmental factors. The research segment encompasses all these three factors to understand disease states better and conclude effective ways to combat them. The growing need for research is thus generating higher demands for biological fluids, tissue samples, and medical data. The research sector is also directly linked to innovation development, thus driving the market growth and need for Biobanks.
Restrain: Sample fetching and maintenance cost.
Each diseased tissue has different dynamics and composition, requiring different preservation methodologies and, thus, maintenance costs. Dedicating a viable shelf life to dead tissues has also been challenging. Most often, it becomes difficult to procure every possible diverse tissue afflicted from some disease state to understand the condition better. The preservation techniques focus on preventing microbial growth and maintaining sample properties. Storing medical data and handling big data also require systems and software, adding to the installment costs.
Opportunity: Advanced therapies and new treatment approaches
Research within the Healthcare segment is largely focusing on genomics, regenerative medicines, and precision medicine to look for chronic disorder management and treatment in the future years. Biobanks are becoming significant tools for studying biological tissues and thus build developments and innovations over these advanced therapies options. The growing advent of precision medicine and regenerative therapies is promising for a variety of chronic disorders, thus grabbing more Biobanks repositories for concluding practical treatment approaches. Study on tumor cells also provides key insights into cancer biology advancements, thus generating more market opportunities.
Biobanks Market: Recent Developments
- U.K biobank developed a risk assessment tool known as QRISK3, which NICE recommends for cardiovascular disease prediction. The tool is a consequence of big data combined with deep learning technology.
- The European Commission is actively supporting and funding a Blueremediomics project, which collects marine microbiome data to develop marine applications in Cosmeceuticals or medicines.
- Qatar has initiated a biobank service to level up medical research. The initiative comes from Hamad Medical Corporation and QatarBioBank (QBB) collaborative efforts.
Biobanks Market: Synopsis
The study of the biobanks market offers revenue and growth data sets of segments provided at the global, regional, and country levels. The report offers the historical data set for 2018-2022 and the forecast period of 2023-2033. For the purpose of analysis, Quadrant Market Insights (QMI) has segregated the Biobanks market into three major segments as follows:
By Component
- Hardware
- Software
- Consumable
- Service
By Sample Type
- Blood Product
- Tissue
- Biological Fluids
- Cell Lines
- Nucleic Acids
- Others
By Application
- Therapeutic
- Research
The regional analysis of the biobanks market is as follows:
North America
- U.S.
- Canada
- Mexico
Europe
- UK
- Germany
- France
- Russia
- Italy
- Spain
- Rest of Europe
Asia-Pacific
- China
- India
- Japan
- Australia
- Rest of Asia-Pacific
Latin America
- Brazil
- Mexico
- Argentina
- Chile
Middle East & Africa
- South Africa
- UAE
- Saudi Arabia
- Israel
Key players operating in the biobanks industry are:
- Brooks Life Sciences
- BioLifeSolutions Inc
- BioCision.
- Cell&Co BioServices
- Hamilton Company
- Thermo Fisher Scientific Inc
- Tecan Trading AG
- TTP Labtech
- Taylor-Wharton
- VWR International, LLC
Biobanks Market: Who Should Purchase, and How It Will Help Readers
- The report is best suited for top-level decision-makers, individuals who are supposed to take a leadership role or require market research to start a business, independent researchers, research institutes, and anyone who wishes to gain detailed strategic insights into the biobanks market.
- This report provides a qualitative and quantitative analysis of the market segments, current trends, estimations, and dynamics of the biobanks market analysis from 2018 to 2033 to identify the prevailing market opportunities.
- Market research and information related to key drivers, restraints, and opportunities are offered.
- Porter's five forces and PESTLE analysis highlight the potency of buyers and suppliers to enable stakeholders' market profit-oriented business decisions and strengthen their supplier-buyer network.
- An in-depth analysis of the biobanks segmentation assists in determining the prevailing market opportunities.
- Major countries in each region are mapped according to their revenue contribution to the global market.
- Market player positioning facilitates benchmarking and provides a clear understanding of the present position of the market players.
- The report includes an analysis of the regional and global biobanks industry trends, key players, market segments, application areas, and market growth strategies.
- The report offers insights from primary interviews and CXOs of major industry players. It also offers a comprehensive contact and event repository to ensure future collaborations among industry stakeholders.
Biobanks Market: Frequently Asked Questions (FAQ)
Q: How big is the biobanks market?
A: The global biobanks market showcased a revenue of USD 49.3 billion in 2022 and is projected to witness a compounded annual growth rate (CAGR) of more than 6% over the forecast period of 2023-2033.
Q: Does the report have several biobanks numbers bifurcated by segments and regions?
A: The report offers a total number of biobanks market, further bifurcated into segments and regions. Please refer to the TOC page for more information.
Q: What are the major trends in the biobanks market?
A: Rise in the geriatric population, extensive growth of the research sector, along with the advent of advanced therapies such as precision medicine, genomics, and regenerative medicine are major factors defining the market of Biobanks within the forecast period.
Q: How can I get the sample Report on the biobanks market?
A: The biobanks market report sample can be obtained on demand from the website. Also, 24*7 chat support and direct call services are provided to procure the sample report
Q: Is it possible to purchase a specific or customized report as per my needs
A: Yes, it is possible to purchase a specific part of the report or edit the scope of the report at your convenience. Feel free to drop us the mail/talk to our customer support or schedule a conversation to procure a customized report.
Report Coverage
- Component
- Sample
- Application
- North America
- Europe
- Asia-Pacific
- Latin America
- Middle East & Africa
- Growing research to combat chronic disorders.
- Advanced therapies and new treatment approaches
- Sample fetching and maintenance cost
Brooks Life Sciences, BioLifeSolutions Inc, BioCision., Cell&Co BioServices, Hamilton Company, Thermo Fisher Scientific Inc, Tecan Trading AG, TTP Labtech, Taylor-Wharton, and VWR International, LLC.
1. Introduction
1.1 Report Description
1.1.1 Definition
1.1.2 Abbreviations
1.2 Key Market Segments
1.3 Benefits to Stakeholders
1.4 Research Methodology
1.4.1 Market Scoping
1.4.1.1 Problem Identification
1.4.1.2 Defining the Market
1.4.2 Market Estimation
1.4.2.1 Data Mining
1.4.2.2 Product Analysis
1.4.2.3 Application Analysis
1.4.2.4 Market Engineering and Forecasting
1.4.2.4.1 Bottom-up Demand Side
1.4.2.4.2 Bottom-up Supply side
1.4.3 Market Authentication
1.4.3.1 Data Triangulation
1.4.3.1.1 Top-down Supply Side
1.4.3.1.2 Top-down Demand Side
1.4.3.1.3 Data Triangulation
1.4.3.2 Primary Insights and Industry feedback
1.4.4 Report Writing
2. Executive Summary
2.1 Market Snapshot
2.2 Macro Trends, Global Economic Factors and Import/Export Insights
2.3 Primary Insights
2.4 Component Insights
2.5 Sample Type Insights
2.6 Application Insights
2.7 Regional Insights
3. Market Overview
3.1 Market Segment and Scope
3.2 Top Investment Pockets
3.3 Key Strategic Initiatives
3.4 Biobanks Market Industry Ecosystem
3.5 Market Evolution
3.6 Patent Analysis
3.7 Technology Landscape
3.8 Regulatory Infrastructure
3.9 Porter’s Analysis
3.9.1 Bargaining Power of Buyer
3.9.2 Bargaining Power of Supplier
3.9.3 Threat of New Entrants
3.9.4 Threat of Substitutes
3.9.5 Industry Rivalry
3.10 PESTLE Analysis
3.11 Market Dynamics
3.11.1 Drivers
3.11.2 Restrains
3.11.3 Opportunities
3.12 Impact of COVID-19 on Biobanks Market
3.13 Russia-Ukraine War Impact on Biobanks Market
3.14 Growth Share Matrix
3.15 Biobanks Market Quadrant
4. Biobanks Market, By Component
4.1 Major Impacting Factors, By Component
4.1.1 Key Market Trends and Growth Factors
4.1.2 Market Size and Forecast, by Region, 2018-2033, (USD Billion)
4.1.3 Market Size and Forecast, by Country, 2018-2033, (USD Billion)
4.2 Hardware
4.2.1 Key Market Trends and Growth Factors
4.2.2 Market Size and Forecast, by Region, 2018-2033, (USD Billion)
4.2.3 Market Size and Forecast, by Country, 2018-2033, (USD Billion)
4.3 Software
4.3.1 Key Market Trends and Growth Factors
4.3.2 Market Size and Forecast, by Region, 2018-2033, (USD Billion)
4.3.3 Market Size and Forecast, by Country, 2018-2033, (USD Billion)
4.4 Consumable
4.4.1 Key Market Trends and Growth Factors
4.4.2 Market Size and Forecast, by Region, 2018-2033, (USD Billion)
4.4.3 Market Size and Forecast, by Country, 2018-2033, (USD Billion)
4.5 Service
4.5.1 Key Market Trends and Growth Factors
4.5.2 Market Size and Forecast, by Region, 2018-2033, (USD Billion)
4.5.3 Market Size and Forecast, by Country, 2018-2033, (USD Billion)
5. Biobanks Market, By Sample Type
5.1 Major Impacting Factors, By Sample Type
5.1.1 Key Market Trends and Growth Factors
5.1.2 Market Size and Forecast, by Region, 2018-2033, (USD Billion)
5.1.3 Market Size and Forecast, by Country, 2018-2033, (USD Billion)
5.2 Blood Product
5.2.1 Key Market Trends and Growth Factors
5.2.2 Market Size and Forecast, by Region, 2018-2033, (USD Billion)
5.2.3 Market Size and Forecast, by Country, 2018-2033, (USD Billion)
5.3 Tissue
5.3.1 Key Market Trends and Growth Factors
5.3.2 Market Size and Forecast, by Region, 2018-2033, (USD Billion)
5.3.3 Market Size and Forecast, by Country, 2018-2033, (USD Billion)
5.4 Biological Fluids
5.4.1 Key Market Trends and Growth Factors
5.4.2 Market Size and Forecast, by Region, 2018-2033, (USD Billion)
5.4.3 Market Size and Forecast, by Country, 2018-2033, (USD Billion)
5.5 Cell Lines
5.5.1 Key Market Trends and Growth Factors
5.5.2 Market Size and Forecast, by Region, 2018-2033, (USD Billion)
5.5.3 Market Size and Forecast, by Country, 2018-2033, (USD Billion)
5.6 Nucleic Acids
5.6.1 Key Market Trends and Growth Factors
5.6.2 Market Size and Forecast, by Region, 2018-2033, (USD Billion)
5.6.3 Market Size and Forecast, by Country, 2018-2033, (USD Billion)
5.7 Others
5.7.1 Key Market Trends and Growth Factors
5.7.2 Market Size and Forecast, by Region, 2018-2033, (USD Billion)
5.7.3 Market Size and Forecast, by Country, 2018-2033, (USD Billion)
6. Biobanks Market, By Application
6.1 Major Impacting Factors, By Application
6.1.1 Key Market Trends and Growth Factors
6.1.2 Market Size and Forecast, by Region, 2018-2033, (USD Billion)
6.1.3 Market Size and Forecast, by Country, 2018-2033, (USD Billion)
6.2 Theraputic
6.2.1 Key Market Trends and Growth Factors
6.2.2 Market Size and Forecast, by Region, 2018-2033, (USD Billion)
6.2.3 Market Size and Forecast, by Country, 2018-2033, (USD Billion)
6.3 Research
6.3.1 Key Market Trends and Growth Factors
6.3.2 Market Size and Forecast, by Region, 2018-2033, (USD Billion)
6.3.3 Market Size and Forecast, by Country, 2018-2033, (USD Billion)
7. Biobanks Market, By Region
7.1 Global Market Trends and Growth Factors
7.2 Market Size and Forecast, by Component, 2018-2033, (USD Billion)
7.3 Market Size and Forecast, by Sample Type, 2018-2033, (USD Billion)
7.4 Market Size and Forecast, by Application, 2018-2033, (USD Billion)
7.5 Market Size and Forecast, by Region, 2018-2033, (USD Billion)
7.6 North America
7.6.1 Key Market Trends and Growth Factors
7.6.2 Market Size and Forecast, by Component, 2018-2033, (USD Billion)
7.6.3 Market Size and Forecast, by Sample Type, 2018-2033, (USD Billion)
7.6.4 Market Size and Forecast, by Application, 2018-2033, (USD Billion)
7.6.5 Market Size and Forecast, by Country, 2018-2033, (USD Billion)
7.6.6 U.S.
7.6.6.1 Market Size and Forecast, by Component, 2018-2033, (USD Billion)
7.6.6.2 Market Size and Forecast, by Sample Type, 2018-2033, (USD Billion)
7.6.6.3 Market Size and Forecast, by Application, 2018-2033, (USD Billion)
7.6.7 Canada
7.6.7.1 Market Size and Forecast, by Component, 2018-2033, (USD Billion)
7.6.7.2 Market Size and Forecast, by Sample Type, 2018-2033, (USD Billion)
7.6.7.3 Market Size and Forecast, by Application, 2018-2033, (USD Billion)
7.6.8 Mexico
7.6.8.1 Market Size and Forecast, by Component, 2018-2033, (USD Billion)
7.6.8.2 Market Size and Forecast, by Sample Type, 2018-2033, (USD Billion)
7.6.8.3 Market Size and Forecast, by Application, 2018-2033, (USD Billion)
7.7 Europe
7.7.1 Key Market Trends and Growth Factors
7.7.2 Market Size and Forecast, by Component, 2018-2033, (USD Billion)
7.7.3 Market Size and Forecast, by Sample Type, 2018-2033, (USD Billion)
7.7.4 Market Size and Forecast, by Application, 2018-2033, (USD Billion)
7.7.5 Market Size and Forecast, by Country, 2018-2033, (USD Billion)
7.7.6 UK
7.7.6.1 Market Size and Forecast, by Component, 2018-2033, (USD Billion)
7.7.6.2 Market Size and Forecast, by Sample Type, 2018-2033, (USD Billion)
7.7.6.3 Market Size and Forecast, by Application, 2018-2033, (USD Billion)
7.7.7 Germany
7.7.7.1 Market Size and Forecast, by Component, 2018-2033, (USD Billion)
7.7.7.2 Market Size and Forecast, by Sample Type, 2018-2033, (USD Billion)
7.7.7.3 Market Size and Forecast, by Application, 2018-2033, (USD Billion)
7.7.8 France
7.7.8.1 Market Size and Forecast, by Component, 2018-2033, (USD Billion)
7.7.8.2 Market Size and Forecast, by Sample Type, 2018-2033, (USD Billion)
7.7.8.3 Market Size and Forecast, by Application, 2018-2033, (USD Billion)
7.7.9 Russia
7.7.9.1 Market Size and Forecast, by Component, 2018-2033, (USD Billion)
7.7.9.2 Market Size and Forecast, by Sample Type, 2018-2033, (USD Billion)
7.7.9.3 Market Size and Forecast, by Application, 2018-2033, (USD Billion)
7.7.10 Italy
7.7.10.1 Market Size and Forecast, by Component, 2018-2033, (USD Billion)
7.7.10.2 Market Size and Forecast, by Sample Type, 2018-2033, (USD Billion)
7.7.10.3 Market Size and Forecast, by Application, 2018-2033, (USD Billion)
7.7.11 Rest of Europe
7.7.11.1 Market Size and Forecast, by Component, 2018-2033, (USD Billion)
7.7.11.2 Market Size and Forecast, by Sample Type, 2018-2033, (USD Billion)
7.7.11.3 Market Size and Forecast, by Application, 2018-2033, (USD Billion)
7.8 Asia-Pacific
7.8.1 Key Market Trends and Growth Factors
7.8.2 Market Size and Forecast, by Component, 2018-2033, (USD Billion)
7.8.3 Market Size and Forecast, by Sample Type, 2018-2033, (USD Billion)
7.8.4 Market Size and Forecast, by Application, 2018-2033, (USD Billion)
7.8.5 Market Size and Forecast, by Country, 2018-2033, (USD Billion)
7.8.6 China
7.8.6.1 Market Size and Forecast, by Component, 2018-2033, (USD Billion)
7.8.6.2 Market Size and Forecast, by Sample Type, 2018-2033, (USD Billion)
7.8.6.3 Market Size and Forecast, by Application, 2018-2033, (USD Billion)
7.8.7 India
7.8.7.1 Market Size and Forecast, by Component, 2018-2033, (USD Billion)
7.8.7.2 Market Size and Forecast, by Sample Type, 2018-2033, (USD Billion)
7.8.7.3 Market Size and Forecast, by Application, 2018-2033, (USD Billion)
7.8.8 Japan
7.8.8.1 Market Size and Forecast, by Component, 2018-2033, (USD Billion)
7.8.8.2 Market Size and Forecast, by Sample Type, 2018-2033, (USD Billion)
7.8.8.3 Market Size and Forecast, by Application, 2018-2033, (USD Billion)
7.8.9 Australia
7.8.9.1 Market Size and Forecast, by Component, 2018-2033, (USD Billion)
7.8.9.2 Market Size and Forecast, by Sample Type, 2018-2033, (USD Billion)
7.8.9.3 Market Size and Forecast, by Application, 2018-2033, (USD Billion)
7.8.10 Rest of Asia-Pacific
7.8.10.1 Market Size and Forecast, by Component, 2018-2033, (USD Billion)
7.8.10.2 Market Size and Forecast, by Sample Type, 2018-2033, (USD Billion)
7.8.10.3 Market Size and Forecast, by Application, 2018-2033, (USD Billion)
7.9 Latin America
7.9.1 Key Market Trends and Growth Factors
7.9.2 Market Size and Forecast, by Component, 2018-2033, (USD Billion)
7.9.3 Market Size and Forecast, by Sample Type, 2018-2033, (USD Billion)
7.9.4 Market Size and Forecast, by Application, 2018-2033, (USD Billion)
7.9.5 Market Size and Forecast, by Country, 2018-2033, (USD Billion)
7.9.6 Brazil
7.9.6.1 Market Size and Forecast, by Component, 2018-2033, (USD Billion)
7.9.6.2 Market Size and Forecast, by Sample Type, 2018-2033, (USD Billion)
7.9.6.3 Market Size and Forecast, by Application, 2018-2033, (USD Billion)
7.9.7 Argentina
7.9.7.1 Market Size and Forecast, by Component, 2018-2033, (USD Billion)
7.9.7.2 Market Size and Forecast, by Sample Type, 2018-2033, (USD Billion)
7.9.7.3 Market Size and Forecast, by Application, 2018-2033, (USD Billion)
7.9.8 Mexico
7.9.8.1 Market Size and Forecast, by Component, 2018-2033, (USD Billion)
7.9.8.2 Market Size and Forecast, by Sample Type, 2018-2033, (USD Billion)
7.9.8.3 Market Size and Forecast, by Application, 2018-2033, (USD Billion)
7.9.9 Chile
7.9.9.1 Market Size and Forecast, by Component, 2018-2033, (USD Billion)
7.9.9.2 Market Size and Forecast, by Sample Type, 2018-2033, (USD Billion)
7.9.9.3 Market Size and Forecast, by Application, 2018-2033, (USD Billion)
7.10 Middle East and Africa
7.10.1 Key Market Trends and Growth Factors
7.10.2 Market Size and Forecast, by Component, 2018-2033, (USD Billion)
7.10.3 Market Size and Forecast, by Sample Type, 2018-2033, (USD Billion)
7.10.4 Market Size and Forecast, by Application, 2018-2033, (USD Billion)
7.10.5 Market Size and Forecast, by Country, 2018-2033, (USD Billion)
7.10.6 South Africa
7.10.6.1 Market Size and Forecast, by Component, 2018-2033, (USD Billion)
7.10.6.2 Market Size and Forecast, by Sample Type, 2018-2033, (USD Billion)
7.10.6.3 Market Size and Forecast, by Application, 2018-2033, (USD Billion)
7.10.7 UAE
7.10.7.1 Market Size and Forecast, by Component, 2018-2033, (USD Billion)
7.10.7.2 Market Size and Forecast, by Sample Type, 2018-2033, (USD Billion)
7.10.7.3 Market Size and Forecast, by Application, 2018-2033, (USD Billion)
7.10.8 Saudi Arabia
7.10.8.1 Market Size and Forecast, by Component, 2018-2033, (USD Billion)
7.10.8.2 Market Size and Forecast, by Sample Type, 2018-2033, (USD Billion)
7.10.8.3 Market Size and Forecast, by Application, 2018-2033, (USD Billion)
7.10.9 Israel
7.10.9.1 Market Size and Forecast, by Component, 2018-2033, (USD Billion)
7.10.9.2 Market Size and Forecast, by Sample Type, 2018-2033, (USD Billion)
7.10.9.3 Market Size and Forecast, by Application, 2018-2033, (USD Billion)
8. Competitive Benchmarking & Company Profiles
8.1 Competitive Benchmarking
8.1.1 Company Market Share
8.1.2 Product Mapping
8.1.3 Competitive Heat map
8.2 Brooks Life Sciences
8.2.1 Company Overview
8.2.2 Financial Analysis
8.2.3 Product Offering
8.2.4 Strategic Initiatives
8.2.5 SWOT
8.2.6 Ansoff Matrix
8.3 BioLifeSolutions Inc
8.3.1 Company Overview
8.3.2 Financial Analysis
8.3.3 Product Offering
8.3.4 Strategic Initiatives
8.3.5 SWOT
8.3.6 Ansoff Matrix
8.4 BioCision.
8.4.1 Company Overview
8.4.2 Financial Analysis
8.4.3 Product Offering
8.4.4 Strategic Initiatives
8.4.5 SWOT
8.4.6 Ansoff Matrix
8.5 Cell&Co BioServices
8.5.1 Company Overview
8.5.2 Financial Analysis
8.5.3 Product Offering
8.5.4 Strategic Initiatives
8.5.5 SWOT
8.5.6 Ansoff Matrix
8.6 Hamilton Company
8.6.1 Company Overview
8.6.2 Financial Analysis
8.6.3 Product Offering
8.6.4 Strategic Initiatives
8.6.5 SWOT
8.6.6 Ansoff Matrix
8.7 Thermo Fisher Scientific Inc
8.7.1 Company Overview
8.7.2 Financial Analysis
8.7.3 Product Offering
8.7.4 Strategic Initiatives
8.7.5 SWOT
8.7.6 Ansoff Matrix
8.8 Tecan Trading AG
8.8.1 Company Overview
8.8.2 Financial Analysis
8.8.3 Product Offering
8.8.4 Strategic Initiatives
8.8.5 SWOT
8.8.6 Ansoff Matrix
8.9 TTP Labtech
8.9.1 Company Overview
8.9.2 Financial Analysis
8.9.3 Product Offering
8.9.4 Strategic Initiatives
8.9.5 SWOT
8.9.6 Ansoff Matrix
8.10 Taylor-Wharton
8.10.1 Company Overview
8.10.2 Financial Analysis
8.10.3 Product Offering
8.10.4 Strategic Initiatives
8.10.5 SWOT
8.10.6 Ansoff Matrix
8.11 VWR International, LLC
8.11.1 Company Overview
8.11.2 Financial Analysis
8.11.3 Product Offering
8.11.4 Strategic Initiatives
8.11.5 SWOT
8.11.6 Ansoff Matrix
9. Industry Connects and Upcoming Seminars
